Multimodal Conversion Therapy with TACE, Zimberelimab, Lenvatinib and S-1, Followed by Debulking Surgery to Prolong Survival for Gallbladder Cancer with Liver Metastasis: A Case Report
Jianbing Sun,
Junqiang Dang,
Qingqiang Wang
et al.
Abstract:Currently, the prognosis of gallbladder cancer (GBC) with liver metastasis is very poor upon the standard first-line chemotherapy or immunochemotherapy. The published articles supported surgery following multimodal conversion therapy of systemic and locoregional treatment might be a feasible way to prolong survival of GBC with liver metastasis. Herein, we reported a 65-year-old female of GBC with locoregional lymph nodes, blood vessels invasion and liver metastasis in clinical practice. She initiated systemic … Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.